-
1
المؤلفون: Yasha S. Modi, Lediana Goduni, Hadi Moini, Andrea Gibson, Nick Boucher, Genevieve Lucas, Dilsher S. Dhoot
المصدر: Eye.
مصطلحات موضوعية: Ophthalmology
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::148acef7e8c80c9c63036dcdfce32418Test
https://doi.org/10.1038/s41433-023-02527-7Test -
2
المؤلفون: Dilsher S. Dhoot, Andrea Gibson, Genevieve Lucas, Yasha S. Modi, Lediana Goduni, Hadi Moini, Nick Boucher
المصدر: Journal of VitreoRetinal Diseases. 5:505-512
مصطلحات موضوعية: medicine.medical_specialty, Visual acuity, genetic structures, Bevacizumab, business.industry, Growth factor, medicine.medical_treatment, Real world outcomes, medicine.disease, eye diseases, 03 medical and health sciences, 0302 clinical medicine, Central retinal vein occlusion, Ophthalmology, 030221 ophthalmology & optometry, Medicine, Ranibizumab, medicine.symptom, business, Dosing Frequency, Macular edema, 030217 neurology & neurosurgery, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4676956a82e20063e3ee5351e4ddbc20Test
https://doi.org/10.1177/2474126421989225Test -
3
المصدر: J Vitreoretin Dis
مصطلحات موضوعية: 0301 basic medicine, medicine.medical_specialty, Visual acuity, Bevacizumab, business.industry, Macular degeneration, medicine.disease, Clinical Practice, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Ophthalmology, Age related, 030221 ophthalmology & optometry, medicine, Original Manuscripts, In patient, medicine.symptom, Ranibizumab, business, Dosing Frequency, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::831bc3766eef2c6fbe0770e0b7f3cc90Test
https://doi.org/10.1177/2474126420960896Test -
4دورية أكاديمية
المؤلفون: Yasha S. Modi (2712325), Lediana Goduni (8557596), Hadi Moini (9453370), Andrea Gibson (10214924), Nick Boucher (9453367), Genevieve Lucas (9453364), Dilsher S. Dhoot (10214927)
مصطلحات موضوعية: Medicine, Pharmacology and Pharmaceutical Sciences not elsewhere classified, antivascular endothelial growth factor, bevacizumab, central retinal vein occlusion, intravitreal aflibercept, ranibizumab, real-world outcomes, treatment frequency, visual acuity
-
5
المؤلفون: Genevieve Lucas, Andrew A. Moshfeghi, Namrata Saroj, Hadi Moini, Nick Boucher, John D Pitcher
المصدر: J Vitreoretin Dis
مصطلحات موضوعية: medicine.medical_specialty, Visual acuity, genetic structures, Bevacizumab, business.industry, Growth factor, medicine.medical_treatment, Diabetic macular edema, Real world outcomes, Clinical Practice, 03 medical and health sciences, 0302 clinical medicine, Ophthalmology, 030221 ophthalmology & optometry, medicine, Original Manuscripts, Ranibizumab, medicine.symptom, business, 030217 neurology & neurosurgery, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4b92b32f3ad7edbdef61b7c5f6671470Test
https://europepmc.org/articles/PMC9979048Test/